The Pharmaceutical Research Team at Biocytogen specializes in advancing therapeutic antibody candidates from concept to early-stage development. Utilizing expertise in pharmacology and gene editing, the team conducts preclinical studies and develops cutting-edge animal models, such as the fully human RenMab mouse, to evaluate drug efficacy and safety. They also play a vital role in regulatory strategy, ensuring compliance and facilitating smooth transitions to IND applications.
View all